ID
45546
Descripción
Principal Investigator: Yick Fu Wong, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA MeSH: Uterine Cervical Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000723 Precision mapping of genetic alterations in cancer can enable better selection of therapies and improved outcomes when combined with new sequencing diagnostics. We describe whole-exome sequences from cervical adenocarcinomas and paired normal samples in Hong Kong Chinese women. These data uncover a heterogeneous genomic landscape but identify commonly aberrant loci including FAT1, ARID1A, ERBB2 and PIK3CA that may provide a focus for the development of individualized targeted therapies for Chinese women with cervical adenocarcinoma.
Link
Palabras clave
Versiones (1)
- 6/1/23 6/1/23 - Chiara Middel
Titular de derechos de autor
Yick Fu Wong, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Subido en
6 de enero de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000723 Sequencing of Cervical Cancer
Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Subject ID, age, clinical stage, gender, race, HPV genotyping, and integrated HPVs at exons of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Sample ID, body site, analyte type, tumor status of samples, histological type, primary metastatic tumor, primary tumor location, tumor stage, tumor grade, tumor treatment, genotyping center, and sequencing center of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
Similar models
Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Subject ID, age, clinical stage, gender, race, HPV genotyping, and integrated HPVs at exons of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
- Sample ID, body site, analyte type, tumor status of samples, histological type, primary metastatic tumor, primary tumor location, tumor stage, tumor grade, tumor treatment, genotyping center, and sequencing center of participants with or without cervical cancer and involved in the "Sequencing of Cervical Cancer" project.
C0449416 (UMLS CUI [1,2])
C2347026 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
C1524063 (UMLS CUI [1,2])